MarderS, DavisM. Second-generation antipsychotics. In: Comprehensive Textbook of Psychiatry. (SadockB, SadockV, RuizP, eds.) Wolters Kluwer: Philadelphia, 2017; pp. 3170–3219.
2.
ModesittT, KubascikE, OttC. Extent of use of long-acting injectable antipsychotics in children and adolescents within Indiana Medicaid. Ment Health Clin, 2018; 8(5):202–207; doi: 10.9740/mhc.2018.09.202
3.
RobinsonD, SubramaniamA, FearisP, et al.Focused ethnographic examination of barriers to use of long-lasting injectable antipsychotics. Psychiatr Serv, 2020; 71(4):337–342; doi: 10.1176/appi.ps.201900236
4.
ScharkoAM, SierackiR, MireskiSJ, et al.Long-acting injectable antipsychotic medication use in youth: A systematic review of the literature along with MedWatch safety data and prescriber attitudes. J Child Adolesc Psychopharmacol, 2025; 35(2):69–79; doi: 10.1089/cap.2024.0050
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
